• Omada Health posted Q2 revenue of $88 million, up 43% year over year, with GAAP net income swinging to $5 million.
• GAAP gross margin rose 7 percentage points to 73%, while adjusted EBITDA turned positive at $11 million.
• Total members increased 45% year over year, with trailing 12-month revenue per total member up about 2% to $284.
• Expanded an HCSC partnership to extend prevention, weight health and hypertension programs across three states, adding access to 1.5 million covered lives.
• Raised 2026 outlook to revenue of $334 million-$340 million and adjusted EBITDA of $21 million-$27 million; CEO Sean Duffy to become executive chair on Jan. 1, 2027, with Wei-Li Shao set to take over as CEO.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omada Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-054266), on August 06, 2026, and is solely responsible for the information contained therein.